Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression

Conditions: Ovarian Cancer; Oligometastatic Disease; Serous Ovarian Tumor Interventions: Drug: Niraparib oral tablets Sponsors: MedSIR Not yet recruiting

https://clinicaltrials.gov/study/NCT06180356

Source: ClinicalTrials.gov - December 22, 2023 Category: Research Source Type: clinical trials